[Prenatal diagnosis and therapy of fetal hemolytic disease with Rh incompatibility].
Between 1966 to 1984 a total of 636 intrauterine foetal transfusions were performed at the Hamburg University Hospital on 280 foetuses suffering from severe erythroblastosis. 54.6% of these foetuses survived. Ascitic fluid was found in 29,6% of the foetuses at the beginning of therapy. The survival rate improved to 22%.
D000649:Amniocentesis; D001805:Blood Transfusion, Intrauterine; D003298:Coombs Test; D004899:Erythroblastosis, Fetal / Q000175:diagnosis* / Q000628:therapy; D005260:Female; D005860:Germany, West; D006801:Humans; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012204:Rh-Hr Blood-Group System; D014463:Ultrasonography
D012204:Rh-Hr Blood-Group System
Pränatale Diagnostik und Therapie des Morbus haemolyticus fetalis bei Rhesus-Inkompatibilität.